行业观察

3月31日，英矽智能宣布与礼来（Lilly）达成药物发现合作。根据协议，礼来将获得一项全球独家许可，用于开发、生产和商业化针对特定适应症、目前处于临床前开发阶段的、具有潜在“同类最佳”水平的新型口服治疗药物。此外，英矽智能与礼来还将围绕礼来选定的靶点开展多项研发项目合作，结合英矽智能先进的Pharma.AI平台能力与礼来在研发推进与疾病领域的深厚专长，共同加速创新候选药物的发现。英矽智能将有资格获

临床试验病友交流群（点击）今天癌度给大家介绍一款正在全国开展临床试验的前沿新药HLX43，以及这款药在非小细胞肺癌、胸腺癌的临床研究和入组申请信息。一、HLX43：靶向PD-L1 的ADC如何“精准打击”肿瘤？ 传统的化疗像是“无差别的轰炸”，杀灭癌细胞但是对正常细胞也有伤害；而靶向治疗和免疫治疗则像“精确制导”，但部分患者仍会耐药。HLX43是一种靶向PD-L1的抗体偶联药物（ADC），它巧妙地

临床试验病友交流群（点击）一、新药快讯1、TROP2的ADC药物芦康沙妥珠单抗联合PD-1一线治疗肺癌纳入优先审评！2026年3月31日，CDE官网显示，芦康沙妥珠单抗和帕博利珠单抗联合疗法拟纳入优先审评，用于经国家药品监督管理局批准的检测评估为 PD-L1 肿瘤比例分数（TPS）≥ 1% 的表皮生长因子受体（EGFR）基因突变阴性和间变性淋巴瘤激酶（ALK）阴性的局部晚期或转移性非小细胞肺癌（N

近日，国家药品监督管理局批准了应脉医疗科技（上海）有限公司（以下简称：应脉医疗）的经导管二尖瓣夹系统这一创新产品的注册申请，又一国产高端器械成功上市。图片来源：NMPA官网01心脑合并潜力产品成功上市应脉医疗成立于2020年，专注于结构性心脏病、血管内疾病介入医疗器械以及神经调控产品。值得一提的是，应脉医疗在成立之初便获得了资本的青睐。2021年10月，应脉医疗宣布完成数亿人民币的B轮融资，该轮融

北京2026年4月1日 /美通社/ -- 在精准医学时代，准确的基因组学分型对于急性B淋巴细胞白血病（B-ALL）的诊断、风险分层和治疗选择具有决定性意义。近日，陆道培分子医学团队题为《Advances in Diagnosis and Classification of B-ALL: Comparative Insights from Updated Guidelines》的研究论文在国际血液学

Advocate HealthMar 31 2026 Advocate Health announced Thursday it will launch the nation's largest hospital-based drone delivery network, transforming how many of its patients receive prescriptions and

University of East AngliaMar 31 2026 A blood test could help identify people at higher risk of cognitive decline years before a traditional diagnosis is possible – according to University of East Angl

NYU Langone HealthMar 31 2026 When Bradley Lawrence gained 25 pounds in two weeks and started experiencing chest pain and shortness of breath, he quickly sought care at NYU Langone Hospital - Brooklyn

Sichuan UniversityApr 1 2026 Tooth root development relies on precise coordination of cellular signals, yet the underlying mechanisms remain unclear. Researchers have uncovered how two proteins, Gli2

Aberystwyth UniversityApr 1 2026 Humor plays a vital role in helping older adults cope with the challenges of ageing and staying socially connected, according to new research. The research team at Abe

From PittconApr 1 2026 Pittcon, the nation’s largest laboratory science conference, announces that Dr. Omar Yaghi, the 2025 recipient of the Nobel Prize in Chemistry, will be the Wallace H. Coulter ke

BMJ GroupApr 1 2026 Having more brothers and sisters may make it easier to cope with the death of a parent, in midlife, particularly when it's the mother who dies, suggests research published online i

Adelaide UniversityApr 1 2026 Lifestyle-behavioral factors and socioeconomic status play an important role in shaping healthy aging, but their effects may differ depending on your DNA, according to a

University of Texas Health Science Center at HoustonApr 1 2026 Multiple regions of the brain engage in fast-moving conversations to understand language, UTHealth Houston researchers have discovered, d

European Association for the Study of ObesityApr 1 2026 Higher fat content in the pancreas of children and adolescents with obesity is associated with an increased level of heart and metabolic risk fa